---
title: "IN8bio regains compliance with Nasdaq $1.00 minimum bid price rule"
url: "https://aibio.space/news/in8bio-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-06-30"
section: "Listings"
tickers: "NASDAQ:INAB"
source: "https://www.sec.gov/Archives/edgar/data/1740279/000119312525152037/d866741d8k.htm"
summary: "Nasdaq notified IN8bio on June 24, 2025 that the company again meets Listing Rule 5550(a)(2). The exchange said the matter is now closed."
---

By the aibio.space news desk.

Sources

- [IN8bio, Inc. 8-K (2025-06-30)](https://www.sec.gov/Archives/edgar/data/1740279/000119312525152037/d866741d8k.htm)

[INAB](https://aibio.space/companies/in8bio/)

2025-06-30

# IN8bio regains compliance with Nasdaq $1.00 minimum bid price rule

Tickers [INAB](https://aibio.space/companies/in8bio/)

Nasdaq notified IN8bio on June 24, 2025 that the company again meets Listing Rule 5550(a)(2). The exchange said the matter is now closed.

## Key facts

- **Company**: IN8bio, Inc. (NASDAQ: INAB)

- **News type**: Listings

- **Primary source**: [IN8bio, Inc. 8-K (2025-06-30)](https://www.sec.gov/Archives/edgar/data/1740279/000119312525152037/d866741d8k.htm)

*The Capitol dome against a blue sky. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

IN8bio, Inc. said Nasdaq has confirmed that the company once again meets the exchange's minimum share price standard.

On June 24, 2025, IN8bio received a formal notification from The Nasdaq Stock Market LLC. The notice confirmed that the company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and that the matter is now closed.

That rule requires listed companies to maintain a minimum bid price of at least $1.00 per share. A company whose stock stays below that level receives a deficiency notice and a set period to recover, and faces delisting if it does not. A notice of regained compliance closes that case.

The company disclosed the notice in a short report filed on June 30, 2025, under the heading of other events.

IN8bio is a Delaware corporation with offices at 350 5th Avenue in New York. Its common stock trades on The Nasdaq Stock Market LLC under the symbol INAB.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

INAB

IN8bio, Inc.

NASDAQ · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/in8bio-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "IN8bio regains compliance with Nasdaq $1.00 minimum bid price rule", 2025-06-30, https://aibio.space/news/in8bio-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/